Physician profile

Aaron M Schatz

Cardiovascular Disease · Richmond, VA

NPI 1932529807

$12,564.25

in general payments reported to CMS, 2019-2025

44 companies · $2,052 in 2025

The $2,052 reported for 2025 was more than what 84% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

See the full distribution for Cardiovascular Disease

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$6,130.34
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$4,650.00
Education$32.27

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Astrazeneca Pharmaceuticals LP $5,030.49 2021-2024 Lokelma, Farxiga, Andexxa
Novartis Pharmaceuticals Corporation $749.80 2019-2025
E.R. Squibb & Sons, L.L.C. $725.24 2022-2025 Camzyos, Eliquis
Abbott Laboratories $702.60 2020-2024 Ensite Precision, Amplatzer Amulet, Thoratec Heartmate 3 Lvas Implant Kit
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $674.61 2022-2025 Lifevest
Boston Scientific Corporation $566.71 2022-2025 Watchman Access System, Opticross, Watchman Flx
Heartflow, INC. $369.28 2023-2025 Ffrct
Alnylam Pharmaceuticals INC. $331.54 2022-2025 Amvuttra, Onpattro
Novo Nordisk INC $327.46 2019-2025 Ozempic, Wegovy, Rybelsus
Edwards Lifesciences Corporation $301.99 2022-2024 Edwards Sapien 3 Transcatheter Heart Valve (Thv)
Amgen INC. $273.35 2022-2025 Repatha, Repatha
Irhythm Technologies, INC. $266.62 2022-2024 Zio Monitor, Zio Xt Patch
Pfizer INC. $253.23 2021-2025
Scpharmaceuticals INC. $217.96 2023-2025
Cvrx, INC. $204.87 2025 Barostim Neo System
Show all 44 companies
CompanyGeneral paymentsYearsTop products
Baxter Healthcare $183.74 2024-2025 Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor
Philips North America LLC $171.87 2024-2025 (5044) Mcot, (5050) Extended Holter, Mcot
Impulse Dynamics (USA) INC. $148.13 2022-2024 Optimizer, Optimizer
Biosense Webster, INC. $148.06 2024-2025 Carto 3
Sanofi-Aventis U.S. LLC $94.15 2023-2024
Abiomed $84.04 2024 Impella
Cardiva Medical, INC. $74.61 2023-2024 Cardiva Vascade Mvp Vvcs 6-12f
Merck Sharp & Dohme LLC $70.94 2022-2025 Verquvo
Medicomp INC $59.12 2022-2024 Telepatch Cardiac Monitor
Actelion Pharmaceuticals US, INC. $48.16 2022
Atricure, INC. $44.52 2024-2025 Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax
Bayer Healthcare Pharmaceuticals INC. $42.98 2022
Medtronic, INC. $42.59 2023-2024 Mycarelink, Ffrangio
Boehringer Ingelheim Pharmaceuticals, INC. $36.83 2022-2023 Jardiance
Amarin Pharma, INC. $36.18 2022
Cleerly, INC. $35.12 2025 Cleerly Ischemia, Cleerly Labs
Recor Medical INC $26.20 2025 Paradise Ultrasound Renal Denervation System
Daiichi Sankyo INC. $24.39 2023 Injectafer
Chiesi USA, INC. $24.19 2025 Cleviprex, Kengreal
Regeneron Healthcare Solutions, INC. $23.58 2024 Evkeeza
Bridgebio Pharma, INC. $22.70 2025 Attruby
Lilly USA, LLC $22.38 2025 Zepbound
Lexicon Pharmaceuticals, INC. $19.92 2023 Inpefa
Kestra Medical Technology Services, INC. $16.98 2024 Assure Wcd
Inspire Medical Systems, INC. $15.42 2024 Inspire
Esperion Therapeutics, INC. $13.94 2022
Altathera Pharmaceuticals LLC $13.93 2024 Sotalol Hydrochloride
Janssen Pharmaceuticals, INC $12.55 2022
Kowa Pharmaceuticals America, INC. $11.28 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Aaron M Schatz

$12,564.25

in general payments reported 2019-2025

Years
2019-2025
Top company
Astrazeneca Pharmaceuticals LP
Context
The $2,052 reported for 2025 was more than what 84% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/2791121/aaron-m-schatz

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.